US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 20, 2017 (9 years ago)

Amitriptyline HCL Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mixup; potentially mislabeled

What was recalled

Amitriptyline HCL Tablets, USP 50 mg, 100 count bottles, Rx Only, Manufactured for: Qualitest Pharmaceuticals Huntsville, AL 35811, Distributed by: Truxton, Inc. Bellmawr, NJ 08031, NDC: 0463-6352-10

Recalling firm
C. O. Truxton
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1115-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Amitriptyline recalls

See all
Class II · Moderate risk Terminated

S-Amitriptyline 10mg/Ml Mdv Inj Soln

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0198-2020
Class II · Moderate risk Terminated

Amitriptyline HCl USP for prescription compounding

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8003-4 D-0474-2018
Class III · Low risk Terminated

Amitriptyline HCl Tablets

Reason Cross Contamination With Other Product: Imipramine

Sandoz Incorporated NDC 0781-1487-01 D-0943-2017
Class II · Moderate risk Terminated

Amitriptyline HCl active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-516-2015